Ixiaro JE and 2-Dose Rabies PrEP: Accelerated Day 0 and 7 Schedules, Vaxchora, Chikungunya, and DMV Stock

SECTION 01 // UPDATED ACIP RABIES GUIDANCE (CPT 90675)

Why ACIP Replaced the $1,400+ 3-Dose Rabies Series With Day 0 and Day 7 PrEP

For decades, Maryland, Washington, D.C., and Northern Virginia travelers preparing for veterinary fieldwork, caving, rural cycling, or extended stays in canine-rabies-endemic corridors across South and Southeast Asia, Sub-Saharan Africa, or Andean South America abandoned rabies pre-exposure prophylaxis (PrEP) after seeing private clinic quotes of $1,350 to $1,680 cash across three separate appointments on Days 0, 7, and 21 or 28.

In May 2022, the CDC Advisory Committee on Immunization Practices (ACIP, published in MMWR Vol. 71, No. 18) overhauled national human rabies pre-exposure schedules based on systematic immunogenicity data showing that two 1.0 mL intramuscular deltoid doses administered on Day 0 and Day 7 using either human diploid cell vaccine (Imovax Rabies, Sanofi Pasteur, NDC 49281-0250-51) or purified chick embryo cell vaccine (RabAvert, Bavarian Nordic, NDC 58160-0964-12) generate 100% seroconversion (rapid fluorescent focus inhibition test RFFIT neutralizing titer >= 0.5 IU/mL) within 7 days of Dose 2 in immunocompetent hosts.

ACIP Risk Categories, 3-Year Memory Window, and Immunocompromised Exceptions

• Most Outbound International Travelers Fall Into ACIP Risk Category 4 (Elevated Risk <= 3 Years): For standard tourists, VFR families, university researchers, and diplomatic assignees whose elevated exposure window lasts fewer than 3 years after completing Dose 1 (Day 0) and Dose 2 (Day 7), zero routine antibody titer checks and zero booster doses are required during that entire 3-year span.
• Sustained Multi-Year Exposure Beyond 3 Years (ACIP Risk Category 3 - Veterinarians, Expats, Wildlife Biologists): Travelers whose occupational or residential rabies exposure continues past Year 3 have two straightforward ACIP options to lock in long-term anamnestic status beyond 3 years: either (a) draw a single RFFIT rabies neutralizing antibody titer during Years 1 to 3 (confirming >= 0.5 IU/mL), or (b) receive a single third booster dose anytime between Day 21 and Year 3 after Dose 1.
• Mandatory 3-Dose Rule for Immunocompromised Patients: Patients on systemic immunosuppressants, B-cell therapies, high-dose corticosteroids, or living with uncontrolled HIV cannot rely on the shortened 2-dose series; ACIP still mandates a three-dose schedule (Days 0, 7, and 21 to 28) followed by laboratory confirmation of a post-vaccination RFFIT titer >= 0.5 IU/mL at least 7 to 14 days after Dose 3. Also note that concurrent Chloroquine or Hydroxychloroquine can blunt intradermal rabies responses, though US providers strictly administer full 1.0 mL intramuscular deltoid doses (never gluteal, where adipose tissue lowers immunogenicity).

SECTION 02 // IXIARO JE, VAXCHORA & CHIKUNGUNYA

Japanese Encephalitis (Ixiaro), Cholera (Vaxchora), and Chikungunya (Ixchiq vs. Vimkunya)

Because private travel franchises earn substantial per-syringe margins on specialty biologics, anxious flyers bound for a five-day hotel conference in central Tokyo, Marina Bay Singapore, or downtown Shanghai are occasionally upsold $850+ vaccine packages they clinically do not need. Pharmacists apply strict epidemiological exposure thresholds across all four high-cost specialty biologics:

SECTION 03 // MULTI-DOSE SERIES & STOCK PLANNER

Interactive Multi-Dose Series Calendar and DMV Wholesaler Lead-Time Planner

Unlike influenza or Tdap syringes sitting inside every retail refrigerator, neighborhood pharmacies in Beltsville (20705), Hyattsville (20782), Silver Spring (20910), D.C., and Northern Virginia rarely tie up $4,000 of cold-shelf capital holding unsolicited boxes of Ixiaro or RabAvert. Instead, retail pharmacies order single-patient NDC units overnight from regional McKesson, Cardinal Health, or AmerisourceBergen depots (arriving in 24 to 48 business hours). Plug your flight date and biologic series into the planner below to verify your Dose 1 order cutoff and Dose 2 completion window.

SECTION 04 // QUANTITATIVE SCHEDULE SCHEMATIC

2-Dose vs. Legacy 3-Dose Rabies PrEP and Accelerated Ixiaro Dosing Timeline

Notice how the harmonized Day 0 and Day 7 spacing on both updated adult Rabies PrEP and FDA-accelerated adult Ixiaro allows an outbound traveler departing Dulles (IAD) for rural Vietnam, Thailand, India, or Indonesia to receive both Dose 1 shots at one appointment (in opposite deltoids) and both Dose 2 shots exactly 7 days later, cutting clinic visits from six trips down to two.

Compare full multi-vaccine cash and Part D budgets in our 2026 DMV Travel Vaccine Cash-Price Ledger, review Medicare Part D $0 retail adjudication rules, or consult our Last-Minute Departure Triage (<14 Days) if your flight leaves next week.

SECTION 05 // CLINICAL SAFETY & REFERENCES

Specialty Biologic Safety Gates and Authoritative Citations

Primary Regulatory and Peer-Reviewed Sources

1. Rao AK, Briggs D, Moore SM, et al. Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the ACIP - United States, 2022 (MMWR Morb Mortal Wkly Rep 71(18):619-627).
2. Hills SL, Walter EB, Atmar RL, Fischer M; ACIP Japanese Encephalitis Vaccines Work Group. Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices (CDC MMWR Recomm Rep 68(2):1-33).
3. US Food and Drug Administration (FDA). FDA Biologics License: Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsorbed), Vaxchora (Cholera Vaccine, Live, Oral), and Chikungunya Vaccines (Ixchiq & Vimkunya) Safety & Approval Records.
4. Wong KK, Burdette E, Mahon BE, Mintz ED, Ryan ET, Reingold AL. Recommendations of the ACIP for Use of Cholera Vaccine (MMWR Morb Mortal Wkly Rep 66(18):482-485).

Frequently Asked Questions